Florida Supreme Court Quickly Dismisses Latest Manuel Valle Appeal

Well, that was quick. Less than an hour ago, the Florida Supreme Court released a ruling saying the court will not hear the latest petition over issues with the new lethal injection drug to be used in Manuel Valle's execution.

Yesterday, Northern Irish neurologist Dr. David Nicholl asked the court to hold off on Valle's execution -- scheduled for tomorrow at 4 p.m. -- by claiming that the Florida Department of Corrections' use of the new sedative drug, pentobarbital, is unlawful.

In its 44-word order, the court dismissed the petition unanimously and said it would not accept a motion for a rehearing on the subject.

If you missed this morning's rundown of the latest petition, click here, or keep reading.

Nicholl's petition was the second to be filed with the Florida Supreme Court over the new drug, but his claims were not the same as the original one filed by Valle's lawyers.

"The Controlled Substances Act prohibits the dispensing of pentobarbital except for legitimate medical purposes, and the purpose of execution is not medical," Nicholl's petition states. "It is incontrovertibly penological."

The first challenge to the use of the drug delayed Valle's original execution date of August 2, after the Florida Supreme Court remanded the case to Miami-Dade Circuit Judge Jacqueline Hogan Scola for a hearing on the constitutionality of pentobarbital.

Scola ruled that Valle's defense "failed to present any credible evidence of any risk of needless suffering," and the Florida Supreme Court unanimously agreed with the lower court's ruling, declaring the new drug constitutional for inmate executions in the state.

At the circuit court hearing, the defense's main witness -- an anesthesiologist -- gave anecdotal evidence about the pain suffered by inmates from other states who have been subject to lethal injections involving pentobarbital, but Scola ruled that without some sort of data, "there is no way to know" exactly how it affects inmates.

Nicholl, on the other hand, was asserting that Floridians have an interest in preventing the Department of Corrections from undermining the law -- again referring to the Controlled Substances Act -- saying the state must "either operate under the law, or demean its authority in the eyes of Florida's citizens."

A neurologist from Belfast, Northern Ireland, and an honorary senior lecturer at City Hospital in Birmingham, England, Nicholl says he has a "direct interest" in Lundbeck, the Danish drugmaker of pentobarbital.

Aside from using Lundbeck drugs in clinical practice and having a financial interest in the company, Nicholl says he also has an ethical interest in the matter.

Petitioner has been directly involved in the movement to prevent the misuse of pentobarbital in executions. Petitioner led a campaign backed by a committee of over 100 neurologists from all over the world against the use of Lundbeck drugs in executions. Petitioner engaged with leading medical journal, the Lancet, exposing the misuse of the drug and calling for distribution changes to be put in place.

Nicholl also argues against the negative consequences for Lundbeck due to the use of the drug "in the barbaric and reprehensible practice of U.S. executions," thus claiming that the company as well as Florida citizens are the losers if Valle gets the juice.

Valle, 61, was convicted of killing a Coral Gables cop in 1978. He's been locked up at the Florida State Prison in Raiford since May 16, 1978, and on death row for just over 30 years now since being sentenced to death on August 4, 1981.

You can read the Florida Supreme Court's brief order here.

Follow The Pulp on Facebook and on Twitter: @ThePulpBPB. Follow Matthew Hendley on Facebook and on Twitter: @MatthewHendley.

KEEP NEW TIMES BROWARD-PALM BEACH FREE... Since we started New Times Broward-Palm Beach, it has been defined as the free, independent voice of South Florida, and we'd like to keep it that way. With local media under siege, it's more important than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" program, allowing us to keep offering readers access to our incisive coverage of local news, food and culture with no paywalls.
Matthew Hendley
Contact: Matthew Hendley